USPlabs OxyELITE Pro Super Thermo DIETARY SUPPLEMENT Manufactured for USPlabs, LLC (Dallas, TX 75220), distributed in the following sizes: 2 count capsules; 10 count capsules; 21 count…
Recalling firm: USPlabs, LLC
USPlabs, LLC received a 423(a), Notification of Opportunity to Initiate a Voluntary Recall, letter from FDA and is recalling products containing Aegeline and associated with serious adverse health events, namely serious liver damage or acute liver failure.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
2 count capsules, UPC # 094922417275; 10 count capsules, UPC # 094922417251; 10 count capsules, UPC # 094922417268; 21 count capsules, UPC # 094922426604; 90 count capsules, UPC # 094922395573; 90 count capsules "Pink Label", UPC # 094922447906; 180 count capsules, UPC # 094922447852
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
USPlabs OxyELITE Pro Super Thermo DIETARY SUPPLEMENT Manufactured for USPlabs, LLC (Dallas, TX 75220), distributed in the following sizes: 2 count capsules; 10 count capsules; 21 count capsules; 90 count capsules; and 180 count capsules.
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 094922395573 | # 094922417268; 21 count capsules, UPC # 094922426604; 90 count capsules, UPC # 094922395573; 90 count capsules "Pink Label", UPC # 094922447906; 180 count capsules, UPC # 094922447852 |
| UPC | 094922417251 | 2 count capsules, UPC # 094922417275; 10 count capsules, UPC # 094922417251; 10 count capsules, UPC # 094922417268; 21 count capsules, UPC # 094922426604; 90 count capsules, UPC # 094922395573; 9 |
| UPC | 094922417268 | # 094922417275; 10 count capsules, UPC # 094922417251; 10 count capsules, UPC # 094922417268; 21 count capsules, UPC # 094922426604; 90 count capsules, UPC # 094922395573; 90 count capsules "Pink Label", UPC # 09 |
| UPC | 094922417275 | 2 count capsules, UPC # 094922417275; 10 count capsules, UPC # 094922417251; 10 count capsules, UPC # 094922417268; 21 count capsules, UPC # 094922426604; 9 |
| UPC | 094922426604 | # 094922417251; 10 count capsules, UPC # 094922417268; 21 count capsules, UPC # 094922426604; 90 count capsules, UPC # 094922395573; 90 count capsules "Pink Label", UPC # 094922447906; 180 count capsules, UPC # 0 |
| UPC | 094922447852 | ; 90 count capsules "Pink Label", UPC # 094922447906; 180 count capsules, UPC # 094922447852 |
| UPC | 094922447906 | 4; 90 count capsules, UPC # 094922395573; 90 count capsules "Pink Label", UPC # 094922447906; 180 count capsules, UPC # 094922447852 |
Recall details
- Recall number
- F-1370-2014
- Event ID
- 66813
- FDA status
- Terminated
- Initiated
- Nov 9, 2013
- Reported
- Jan 22, 2014
- Classified
- Jan 15, 2014
- Terminated
- Oct 13, 2015
- Quantity
- 2,166,328 units
- Location
- Dallas, TX, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Press Release
Where it was distributed
Worldwide distribution including the following Worldwide distribution including the following international countries: Ecuador, Russia, UAE, South America, Dominican Republic, Kuwait, Philippines, Indonesia, Egypt, Panama, China, and Argentina.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.